References
1. Pickup JC: Inflammation and activated innate immunity in the
pathogenesis of type 2 diabetes. Diabetes Care 2004,
27(3):813-23.
2. Dandona PA, Aljada , et al.: Inflammation : the lind between
insulin resistance, obesity and diabetes. Trends Immunol 2004,
25(1):4-7.
3. Hotamisligil GS: Inflammatory pathways and insulin action. Int
J Obes Relat Metab Disord 2003, 27(Suppl 3):S53-5.
4. Nuamah MA, Yura S, Sagawa N, Itoh H, Mise H, Korita D, kakui k,
Takemura M, Ogawa Y, Nakao K, Fujii S: Significant increase in
maternal plasma leptin concentration in induce delivery: a
possible contribution of pro-inflammatory cytokines to placental
leptin secretion. Endocr J 2004, 51(2):177-87.
5. Sitaraman S, Liu X, Charrier L, Gu LH, Ziegler TR, Gewirtz A, Merlin
D: Colonic leptin: source of a novel proinflammatory
cytokine involved in IBD. FASEB J 2004, 18(6):696-8. Epub 2004
Feb 20.
6. Gaetke LM, Oz HS, Frederich RC, McClain CJ: Anti-TNF-alpha
antibody normalizes serum leptin in IL-2 deficient mice. J Am
Coll Nutr 2003, 22(5):415-20.
7. Rajala MW, Scherer PE: Minireview: The adipocyte at the crossroads
of energy homeostasis, inflammation, and
atherosclerosis. Endocrinology 2003, 144(9):3765-73.
8. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W,
et al.: FIZZI, a novel cysteine-rich secreted protein associated
with pulmonary inflammation, defines new gene family.
Embo J 2000, 19(15):4046-55.
9. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et
al.: The hormone resistin links obesity to diabetes. Nature
2001, 409(6818):307-12.
10. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM: Resistin gene
expression in human adipocytes is not related to insulin
resistance. Obes Res 2002, 10(1):1-5.
11. Ternan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar
S: Resistin, central obesity, and type 2 diabetes. Lancet 2002,
359(9300):46-7.
12. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton
C, et al.: Resistin is expressed in human macrophages and
directly regulated by PPARagnna activators. Biochem Biophys
Res Commun 2003, 300(2):472-6.
13. Donovan JA, Koretzky GA: CD45 and the immune response. J
Am Soc Nephrol 1993, 4(4):976-85.
14. Gomez-Ambrosi J, Fruhbeck G: Do resistin and resistin-linke
molecules also link obesity to inflammatory diseases? Ann
Intern Med 2001, 135(4):306-7.
15. Villena JA, Kim KH, Sul HS: Pref-1 and ADSF/resistin: two
secreted factors inhibiting adipose tissue development. Horm
Metab Res 2002, 34(11–12):664-7.
16. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Waston W, Kerr K,
Jones R, Zhu Q, Considine RV: Serum resistin (FIZZ3) protein is
increased in obese humans. J Clin Endocrinol Metab 2003,
88(11):5452-5.
17. Heilbronn LK, Rood J, et al.: Relationship between serum resistin
concentration and insulin resistance in nonobese, obese,
and obese diabetic subjects. J Clin Endocrinol Metab 2004,
89(4):1844-8.
18. Mc Ternan PG, Fisher FM, et al.: Resistin and type 2 diabetes: regulation
of resistin expression by insulin and rosiglitazone and
the effects of recombinant resistin on lipid and glucose
metabolism in human differentiated adipocytes. J Clin Endocrinol
Metab 2003, 88(12):6098-106.
19. Volarova de courten B, Degawa-Yamauchi M, Considin RV, Tatarnni
PA: High serum resistin is associated with an increase in adiposity
but not a worsening of insulin resistance in Pima
Indian. Diabetes 2004, 53(5):1279-84.
20. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Eatrada E, Seip R,
Orlova C, Mantzoros CS: Circulating resistin levels are not
associated with obesity or insulin resistance in humans and
not regulated by fasting or leptin administration: cross-sectional
and interventional studies in normal, insulin-resistant,
and diabetic subjects. J Clin EndocrinolMetab 2003,
88(10):4848-56.
21. Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H,
Kawahara Y, Yamazaki M, Ogata M, Hasegawa G, Nakamura N,
Yoshikawa T, Nakano K, Ohta M: Enzyme-linked immunosorbent
assay for circulating human resistin: resistin concentrations
in normal subjects and patients with type 2 diabetes.
Clin Chim Acta 2004, 339(1–2):57-63.
22. Valsamakis G, Mc Ternan PG, Chetty R, Al Daghri N, Field A, Hanif
W, Barnett AH, Kumar S: Modest weight loss and reduction in
waist circumference after medical treatment are associated
with favorable changes in serum adipocytokines. Metabolism
2004, 53(4):430-4.
23. Wilson PW: Assessing coronary heart disease risk with traditional
and novel risk factors. Clin Cardiol 2004, 27(6 Suppl
3):III7-11.
24. Mather HM, Keen H: The South all Diabetes Survey: prevalence
of known diabetes in Asians and Europeans. Br Med J
1985, 291:1081-1084.
Jaber LA, Slaughter RL, Grunberger G: Diabetes and related metabolic
risk factors among Arab Americans. Ann Pharmacother
1995, 29(6):573-6.
26. Kadiki OA, Roaded RB: Epidemiological and clinical patterns of
diabetes mellitus in Benghazi, Libyan Arab Jamahiriya. East
Mediterr Health J 1999, 5(1):6-13.
27. Abdella NA, Khogali MM, Salman AD, Ghuneimi SA, Bajaj JS: Pattern
of non-insulin dependent diabetes mellitus in Kuwait. Diabetes
Res Clin Pract 1995, 29(2):129-36.
28. McNeely MJ, Boyko EJ: Type 2 diabetes prevalence in Asian
Americans: results of a national health survey. Diabetes Care
2004, 27(1):66-9.
29. Bajaj M, Banerji MA: Type 2 diabetes in South Asians: a pathophysiologic
focus on the Asian-Indian epidemic. Curr Diab Rep
2004, 4(3):213-8.
30. Matthews DRHJ, Rudenski AS, Naylor BA, Treacher DF, Turner RL:
Homeostasis model assessment: insulin resistance and b-cell
function from fasting plasma glucose and insulin concentration
in man. Diabetologia 1985, 28:412-419.
31. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, Capeau
J, Bastard JP: Systemic low-grade inflammation is related to
both circulating and adipose tissue TNFalpha, leptin and IL-
6 levels in obese women. Int J Obes Relat Metab Disord . 2004 Jun
32. Rangwala SM, Rich AS, Rhoades B, Shapiro JS, Obici S, Rossetti L,
Lazar MA: Abnormal Glucose Homeostasis due to Chronic
Hyperresistinemia. Diabetes in press. 2004 Jun 9
33. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ:
Plasma resistin, adiponectin and leptin levels in lean and
obese subjects: correlation with insulin resistance. Eur J
Endocrinol 2003, 149(4):331-5.
34. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A,
Saruta T: Correlation between serum resistin level and adiposity
in obese individuals. Obes Res 2003, 11(8):997-1001.